(MKSI) MKS Instruments - Overview
Sector: TechnologyIndustry: Scientific & Technical Instruments | Exchange NASDAQ (USA) | Currency USD | Market Cap: 16.387m | Total Return 165% in 12m
Stock: Semiconductor Equipment, Lasers, Measurement, Control, Plating
Total Rating 64
Risk 78
Buy Signal -0.12
| Risk 5d forecast | |
|---|---|
| Volatility | 61.3% |
| Relative Tail Risk | -3.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.78 |
| Alpha | 128.15 |
| Character TTM | |
|---|---|
| Beta | 2.816 |
| Beta Downside | 2.025 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.11% |
| CAGR/Max DD | 0.64 |
EPS (Earnings per Share)
Revenue
Description: MKSI MKS Instruments March 03, 2026
MKS Inc. (NASDAQ: MKSI) supplies foundational technology solutions for semiconductor manufacturing, electronics packaging, and specialty industrial markets. Headquartered in Andover, Massachusetts, the company operates through three primary segments: Vacuum Solutions (VSD), Photonics Solutions (PSD), and Material Solutions (MSD). The VSD segment focuses on pressure measurement, flow control, and gas delivery systems, which are critical for maintaining the precise vacuum environments required in semiconductor wafer fabrication.
The Photonics Solutions segment provides lasers, precision motion control, and vibration isolation systems, while the Material Solutions division specializes in surface modification and plating chemistry. As a key supplier in the semiconductor capital equipment industry, MKS Instruments supports the complex manufacturing processes necessary for advanced logic and memory chip production. The company utilizes a global sales network comprising direct channels and independent distributors to serve major markets in the United States and Asia. For deeper financial analysis and valuation metrics, investors can review the companys profile on ValueRay.
Headlines to watch out for
- Semiconductor capital expenditure drives equipment demand
- Electronics manufacturing growth boosts component sales
- Industrial applications expand technology solution market
- Global supply chain disruptions impact production costs
- Currency fluctuations affect international revenue and expenses
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 295.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.25 > 1.0 |
| NWC/Revenue: 40.28% < 20% (prev 47.39%; Δ -7.11% < -1%) |
| CFO/TA 0.07 > 3% & CFO 645.0m > Net Income 295.0m |
| Net Debt (-378.0m) to EBITDA (869.0m): -0.43 < 3 |
| Current Ratio: 2.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (68.0m) vs 12m ago 0.44% < -2% |
| Gross Margin: 45.19% > 18% (prev 0.48%; Δ 4.47k% > 0.5%) |
| Asset Turnover: 45.21% > 50% (prev 41.73%; Δ 3.47% > 0%) |
| Interest Coverage Ratio: 2.48 > 6 (EBITDA TTM 869.0m / Interest Expense TTM 212.0m) |
Altman Z'' 1.96
| A: 0.18 (Total Current Assets 2.51b - Total Current Liabilities 927.0m) / Total Assets 8.80b |
| B: 0.08 (Retained Earnings 711.0m / Total Assets 8.80b) |
| C: 0.06 (EBIT TTM 525.0m / Avg Total Assets 8.69b) |
| D: 0.10 (Book Value of Equity 618.0m / Total Liabilities 6.08b) |
| Altman-Z'' Score: 1.96 = BBB |
Beneish M -2.98
| DSRI: 0.97 (Receivables 651.0m/615.0m, Revenue 3.93b/3.58b) |
| GMI: 1.05 (GM 45.19% / 47.62%) |
| AQI: 1.00 (AQ_t 0.59 / AQ_t-1 0.59) |
| SGI: 1.10 (Revenue 3.93b / 3.58b) |
| TATA: -0.04 (NI 295.0m - CFO 645.0m) / TA 8.80b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of MKSI shares?
As of March 28, 2026, the stock is trading at USD 223.18 with a total of 691,219 shares traded.
Over the past week, the price has changed by -1.74%, over one month by -8.70%, over three months by +37.21% and over the past year by +165.00%.
Over the past week, the price has changed by -1.74%, over one month by -8.70%, over three months by +37.21% and over the past year by +165.00%.
Is MKSI a buy, sell or hold?
MKS Instruments has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy MKSI.
- StrongBuy: 7
- Buy: 4
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MKSI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 292.1 | 30.9% |
| Analysts Target Price | 292.1 | 30.9% |
MKSI Fundamental Data Overview March 27, 2026
P/E Trailing = 55.8899
P/E Forward = 10.3627
P/S = 4.1687
P/B = 5.6176
P/EG = 1.3236
Revenue TTM = 3.93b USD
EBIT TTM = 525.0m USD
EBITDA TTM = 869.0m USD
Long Term Debt = 4.15b USD (from longTermDebt, last quarter)
Short Term Debt = 51.0m USD (from shortTermDebt, last quarter)
Debt = 297.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -378.0m USD (from netDebt column, last quarter)
Enterprise Value = 16.01b USD (16.39b + Debt 297.0m - CCE 675.0m)
Interest Coverage Ratio = 2.48 (Ebit TTM 525.0m / Interest Expense TTM 212.0m)
EV/FCF = 32.28x (Enterprise Value 16.01b / FCF TTM 496.0m)
FCF Yield = 3.10% (FCF TTM 496.0m / Enterprise Value 16.01b)
FCF Margin = 12.62% (FCF TTM 496.0m / Revenue TTM 3.93b)
Net Margin = 7.51% (Net Income TTM 295.0m / Revenue TTM 3.93b)
Gross Margin = 45.19% ((Revenue TTM 3.93b - Cost of Revenue TTM 2.15b) / Revenue TTM)
Gross Margin QoQ = 40.46% (prev 46.66%)
Tobins Q-Ratio = 1.82 (Enterprise Value 16.01b / Total Assets 8.80b)
Interest Expense / Debt = 17.17% (Interest Expense 51.0m / Debt 297.0m)
Taxrate = 2.96% (9.00m / 304.0m)
NOPAT = 509.5m (EBIT 525.0m * (1 - 2.96%))
Current Ratio = 2.71 (Total Current Assets 2.51b / Total Current Liabilities 927.0m)
Debt / Equity = 0.11 (Debt 297.0m / totalStockholderEquity, last quarter 2.72b)
Debt / EBITDA = -0.43 (Net Debt -378.0m / EBITDA 869.0m)
Debt / FCF = -0.76 (Net Debt -378.0m / FCF TTM 496.0m)
Total Stockholder Equity = 2.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.39% (Net Income 295.0m / Total Assets 8.80b)
RoE = 11.54% (Net Income TTM 295.0m / Total Stockholder Equity 2.56b)
RoCE = 7.83% (EBIT 525.0m / Capital Employed (Equity 2.56b + L.T.Debt 4.15b))
RoIC = 7.38% (NOPAT 509.5m / Invested Capital 6.90b)
WACC = 15.90% (E(16.39b)/V(16.68b) * Re(15.89%) + D(297.0m)/V(16.68b) * Rd(17.17%) * (1-Tc(0.03)))
Discount Rate = 15.89% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.67%
[DCF] Terminal Value 59.51% ; FCFF base≈448.4m ; Y1≈543.2m ; Y5≈889.0m
[DCF] Fair Price = 90.40 (EV 5.70b - Net Debt -378.0m = Equity 6.08b / Shares 67.2m; r=15.90% [WACC]; 5y FCF grow 22.60% → 3.0% )
EPS Correlation: 0.87 | EPS CAGR: -2.44% | SUE: 1.68 | # QB: 1
Revenue Correlation: 50.71 | Revenue CAGR: 9.22% | SUE: 0.42 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.37 | Chg7d=+0.011 | Chg30d=+0.220 | Revisions Net=+1 | Analysts=12
EPS current Year (2026-12-31): EPS=9.89 | Chg7d=+0.047 | Chg30d=+0.820 | Revisions Net=+1 | Growth EPS=+25.5% | Growth Revenue=+13.6%
EPS next Year (2027-12-31): EPS=11.98 | Chg7d=+0.055 | Chg30d=+1.085 | Revisions Net=+2 | Growth EPS=+21.1% | Growth Revenue=+10.8%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 14.1% (Discount Rate 15.9% - Earnings Yield 1.8%)
[Growth] Growth Spread = -2.5% (Analyst 11.6% - Implied 14.1%)
P/E Forward = 10.3627
P/S = 4.1687
P/B = 5.6176
P/EG = 1.3236
Revenue TTM = 3.93b USD
EBIT TTM = 525.0m USD
EBITDA TTM = 869.0m USD
Long Term Debt = 4.15b USD (from longTermDebt, last quarter)
Short Term Debt = 51.0m USD (from shortTermDebt, last quarter)
Debt = 297.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -378.0m USD (from netDebt column, last quarter)
Enterprise Value = 16.01b USD (16.39b + Debt 297.0m - CCE 675.0m)
Interest Coverage Ratio = 2.48 (Ebit TTM 525.0m / Interest Expense TTM 212.0m)
EV/FCF = 32.28x (Enterprise Value 16.01b / FCF TTM 496.0m)
FCF Yield = 3.10% (FCF TTM 496.0m / Enterprise Value 16.01b)
FCF Margin = 12.62% (FCF TTM 496.0m / Revenue TTM 3.93b)
Net Margin = 7.51% (Net Income TTM 295.0m / Revenue TTM 3.93b)
Gross Margin = 45.19% ((Revenue TTM 3.93b - Cost of Revenue TTM 2.15b) / Revenue TTM)
Gross Margin QoQ = 40.46% (prev 46.66%)
Tobins Q-Ratio = 1.82 (Enterprise Value 16.01b / Total Assets 8.80b)
Interest Expense / Debt = 17.17% (Interest Expense 51.0m / Debt 297.0m)
Taxrate = 2.96% (9.00m / 304.0m)
NOPAT = 509.5m (EBIT 525.0m * (1 - 2.96%))
Current Ratio = 2.71 (Total Current Assets 2.51b / Total Current Liabilities 927.0m)
Debt / Equity = 0.11 (Debt 297.0m / totalStockholderEquity, last quarter 2.72b)
Debt / EBITDA = -0.43 (Net Debt -378.0m / EBITDA 869.0m)
Debt / FCF = -0.76 (Net Debt -378.0m / FCF TTM 496.0m)
Total Stockholder Equity = 2.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.39% (Net Income 295.0m / Total Assets 8.80b)
RoE = 11.54% (Net Income TTM 295.0m / Total Stockholder Equity 2.56b)
RoCE = 7.83% (EBIT 525.0m / Capital Employed (Equity 2.56b + L.T.Debt 4.15b))
RoIC = 7.38% (NOPAT 509.5m / Invested Capital 6.90b)
WACC = 15.90% (E(16.39b)/V(16.68b) * Re(15.89%) + D(297.0m)/V(16.68b) * Rd(17.17%) * (1-Tc(0.03)))
Discount Rate = 15.89% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.67%
[DCF] Terminal Value 59.51% ; FCFF base≈448.4m ; Y1≈543.2m ; Y5≈889.0m
[DCF] Fair Price = 90.40 (EV 5.70b - Net Debt -378.0m = Equity 6.08b / Shares 67.2m; r=15.90% [WACC]; 5y FCF grow 22.60% → 3.0% )
EPS Correlation: 0.87 | EPS CAGR: -2.44% | SUE: 1.68 | # QB: 1
Revenue Correlation: 50.71 | Revenue CAGR: 9.22% | SUE: 0.42 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.37 | Chg7d=+0.011 | Chg30d=+0.220 | Revisions Net=+1 | Analysts=12
EPS current Year (2026-12-31): EPS=9.89 | Chg7d=+0.047 | Chg30d=+0.820 | Revisions Net=+1 | Growth EPS=+25.5% | Growth Revenue=+13.6%
EPS next Year (2027-12-31): EPS=11.98 | Chg7d=+0.055 | Chg30d=+1.085 | Revisions Net=+2 | Growth EPS=+21.1% | Growth Revenue=+10.8%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 14.1% (Discount Rate 15.9% - Earnings Yield 1.8%)
[Growth] Growth Spread = -2.5% (Analyst 11.6% - Implied 14.1%)